Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518751 | SCV000615218 | uncertain significance | not specified | 2017-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001090958 | SCV001246753 | uncertain significance | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001834675 | SCV002992213 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 117 of the SGCA protein (p.Arg117Trp). This variant is present in population databases (rs200075504, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 448352). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SGCA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV001834675 | SCV003931661 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834675 | SCV002087561 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2019-11-11 | no assertion criteria provided | clinical testing |